Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy

NCT05174468 is registered in ClinicalTrials.gov with Breathe BioMedical Inc as lead sponsor.

NCT NCT05174468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05174468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy
Lead sponsor
Breathe BioMedical Inc
Phase
Observational
Overall status
Terminated
Start date
September 22, 2022
Completion date
July 12, 2023
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer